Euroapi S.A. (EPA: EAPI)
4.158
+0.176 (4.42%)
Aug 30, 2024, 5:35 PM CET
Euroapi Company Description
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use.
It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids.
The company was incorporated in 2020 and is based in Paris, France.
Euroapi S.A.
Country | France |
Founded | 2020 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 3,329 |
CEO | Ludwig De Mot |
Contact Details
Address: 15 Rue Traversiere Paris, 75012 France | |
Phone | 33 1 89 20 62 00 |
Website | euroapi.com |
Stock Details
Ticker Symbol | EAPI |
Exchange | Euronext Paris |
Reporting Currency | EUR |
ISIN Number | FR0014008VX5 |
SIC Code | 2833 |